resorcinol bis-ethylhexanoate est-il sûr pendant la grossesse ?
Searches of regulatory and literature databases (ECHA registration/C&L, PubMed, CIR, CosIng, EWG) did not identify a harmonised CLP classification, an EU Annex II/III restriction, SCCS/CIR safety assessment, or peer‑reviewed reproductive/developmental studies for 'resorcinol bis‑(2‑ethylhexanoate)' (or close name variants). In the absence of reproductive or endocrine‑activity data and with no EU ban/restriction, hazard and mechanism are scored 0. Exposure is scored 1 (low but measurable) because the compound is an organic, lipophilic ester (typical cosmetic esters have at least low dermal absorption). Sources searched did not return evidence of reproductive hazard.
Related ingredients
Frequently asked questions
- resorcinol bis-ethylhexanoate est-il sûr pendant la grossesse ?
- Searches of regulatory and literature databases (ECHA registration/C&L, PubMed, CIR, CosIng, EWG) did not identify a harmonised CLP classification, an EU Annex II/III restriction, SCCS/CIR safety assessment, or peer‑reviewed reproductive/developmental studies for 'resorcinol bis‑(2‑ethylhexanoate)' (or close name variants). In the absence of reproductive or endocrine‑activity data and with no EU ban/restriction, hazard and mechanism are scored 0. Exposure is scored 1 (low but measurable) because the compound is an organic, lipophilic ester (typical cosmetic esters have at least low dermal absorption). Sources searched did not return evidence of reproductive hazard.
- resorcinol bis-ethylhexanoate est-il sûr pendant l'allaitement ?
- No evidence found for reproductive or lactation-specific toxicity or mechanistic endocrine activity. By analogy with topical cosmetic esters, low but measurable maternal absorption could allow minimal transfer to breastmilk; therefore exposure scored 1. No authoritative sources (EU Annex, harmonised H‑code, SCCS/CIR) indicate restriction for lactation.
- resorcinol bis-ethylhexanoate est-il sûr pour la peau de bébé ?
- No infant-specific toxicology or clinical safety data were located. Following your rule to increase exposure by +1 for baby skin when the adult exposure is measurable, baby exposure is scored 2 (moderate) because infants have higher surface‑area‑to‑weight and an immature barrier. Hazard and mechanism remain 0 in the absence of data showing reproductive, developmental, or endocrine activity.
- Comment VeriMom évalue-t-il resorcinol bis-ethylhexanoate ?
- VeriMom évalue resorcinol bis-ethylhexanoate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à resorcinol bis-ethylhexanoate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à resorcinol bis-ethylhexanoate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.